On Demand: 5th Annual Diabetes, Obesity, & Metabolic Disease Conference
|
$399.20
Use promo code (Limited Time Offer)
15 CREDITS
  Hurry! Offer expires January 1, 2023 at 11:59 pm ET!
|
|
A collection of recorded video lectures from our recent 5th Annual Diabetes, Obesity, & Metabolic Disease ConferenceCourse Content
| Session | Title | Faculty |
| Session 1 (38 minutes) | Diabetes On A Budget | J. Shubrook, DO |
| Session 2 (52 minutes) | Obesity and Microalbuminuria: Important Overlooked Signals of Risk or Cardiorenal Disease Progression | M. Weir, MD |
| Session 3 (54 minutes) | Differentiating the Different Presentations of Diabetes | J. Shubrook, DO |
| Session 4 (64 minutes) | What's New in the Treatment of Diabetic Kidney Disease | M. Weir, MD |
| Session 5 (76 minutes) | Cases in Glucose Control, Diabetes and Cardio-Renal Disease | J. Shubrook, DO & M. Weir, MD |
| Session 6 (56 minutes) | Practical Approaches to Prescribing Weight-Loss Medications in the Patient with Obesity | D. Horn, DO |
| Session 7 (40 minutes) | New Directions in Obesity Pharmacotherapy | D. Ryan, MD |
| Session 8 (45 minutes) | Reversing Diabetes: A Coordinated Approach to Reverse the Presence of Diabetes | D. Ryan, MD |
| Session 9 (59 minutes) | Managing the Co-Morbidities of Obesity | D. Horn, DO |
| Session 10 (51 minutes) | Obesity Case Studies | D. Ryan, MD & D. Horn, DO |
| Session 11 (73 minutes) | Nonalcohoic Fatty Liver Disease (NAFLD): The Essentials | B. Pearlman, MD |
| Session 12 (40 minutes) | NAFLD/NASH Case Studies | B. Pearlman, MD |
| Session 13 (59 minutes) | Update on Resistant Hypertension | J. Basile, MD |
| Session 14 (57 minutes) | Update on Lipid Guidelines and Drug Treatment | P. Jones. MD |
| Session 15 (59 minutes) | What's New in CVD Risk Assessment and Lipid Drug Therapy | P. Jones, MD |
| Session 16 (56 minutes) | Case Studies in Hypertension and Lipid Management | J. Basile, MD & P. Jones, MD |
Program Overview
Continuing Education Company has been organizing its Primary Care Conference Series for over 27 years. The On Demand: 5th Annual Diabetes, Obesity and Metabolic Disease Conference was designed to update primary care clinicians in rapidly changing therapeutic areas. The emphasis is on practical and useful information for clinical practice. The CME conference will educate and promote improved patient outcomes in a broad range of therapeutic areas commonly encountered in the primary care practice.
Cardiometabolic disorders are a cluster of health conditions associated with cardiovascular disease and type 2 diabetes. It is estimated that over 1/3 of American’s suffer from a cardiometabolic disorder. The associated morbidity and mortality deserve increased clinical attention as we address risk factors predisposing individuals to these disorders. This program will help identify these conditions and their related complications to enable clinicians to appropriately intervene with evidence-based treatments and risk-factor control while improving patient education.
Learning Objectives:
As a result of this educational activity, participants should be better able to:
- Diagnose and identify cardiometabolic risk factors, including diabetes, dyslipidemia, hypertension, and obesity.
- Integrate evidence-based strategies and recent guidelines for the screening, prevention, and treatment of cardiometabolic risk factors and their comorbidities in clinical practice.
- Incorporate appropriate interventions, including lifestyle modifications, nutrition counseling, and drug and surgical therapies, based on a specific patient’s risk profile.
Post-Test and Evaluation:
After completing the CME activity, you must successfully complete a post-test and fill out a program evaluation form. You will then be able to view and print your CME certificate. Login into CME365 to view your transcript and reprint your certificate at any time.
Faculty
Jan N. Basile, MD, FACP, FASH, FAHA
Professor of Medicine
Seinsheimer Cardiovascular Health Program
Medical University of South Carolina
Ralph H Johnson VA Medical Center
Vice-Chair of Clinical Programs AHA Council of Hypertension
Charleston, SC
Deborah Bade Horn, DO, MPH, MFOMA
Medical Director at the UT Center for Obesity Medicine and Metabolic Performance
Assistant Professor, University of Texas McGovern Medical School, Dept. of Surgery
Program Director, UT Allison Family Foundation Fellowship in Clinical Obesity Medicine and Metabolic Performance
University of Texas McGovern School of Medicine
Houston, Texas
Peter Howard Jones, MD, FACP, FNLA
Director, Weight Management Center
Houston Methodist Hospital
Associate Professor of Medicine
Center for Cardiovascular Disease Prevention
Houston Methodist DeBakey Heart and Vascular Center
Baylor College of Medicine
Houston, TX
Brian Pearlman, MD, FACP, FAASLD, AAHIVS
Medical Director, Center for Hepatitis C, Wellstar Atlanta Medical Center
Professor of Medicine, Medical College of Georgia
Professor of Medicine, Emory School of Medicine
Atlanta, GA
Donna H. Ryan, MD, FACP
Professor Emerita
Pennington Biomedical Research Center
Baton Rouge, LA
Jay H. Shubrook, DO, FAAFP, FACOFP
Professor, Primary Care Department
Director of Clinical Research
Director of Diabetes Services
Touro University California
Vallejo, CA
Matthew R. Weir, MD
Professor of Medicine
Chief of Nephrology Division
University of Maryland School of Medicine
Baltimore, MD, UCF-COM
Clinical Associate Professor, SU-COM
Winter Park, FL
Accreditation
AMA PRA Category 1 Credits™: Continuing Education Company, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Continuing Education Company designates this enduring material for a maximum of 15 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 15 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Please allow 6-8 weeks for your MOC points to appear on your ABIM records.
AAPA: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 15 hours of Category 1 credit for completing this activity.
AANPCB: The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Nurse Practitioners may receive a maximum of 15 hours of participation, 10 of which can be used towards Pharmacology, for completing this activity.
Release Date: 5/13/2020
Expiration Date: 5/13/2023 (Date after which this enduring material is no longer certified for credit.)
Medium: Internet/Enduring Material, Video/Audio
Faculty/Planning Committee Disclosures
Review and Planning Committee Disclosures:
The following individuals have indicated that he/she (nor spouse/partner) has no relevant financial relationships with a commercial interest that may impact upon this CME activity:
- Raymond E. Major - Reviewer
- Walter Ejnes, CHCP - Reviewer & Planning Committee (Continuing Education Company)
- Beth Townsend - Reviewer (Continuing Education Company)
- Su Barnwell - Planning Committee (Continuing Education Company)
Faculty Disclosures:
The following individuals have indicated that he/she (nor spouse/partner) have no relevant financial relationships with a commercial interest that may impact upon this CME activity:
| Faculty | Disclosure |
| Jan N. Basile, MD – Chair/Moderator | Consultant: Medtronic Adjudication Committee and Up-to-Date (Hypertension Section) Consultant, Research Grant: ReCor (RADIANCE I and II) Research Grant: Ablative Solutions (Target BP I) and Eli Lilly |
| Deborah B. Horn, DO | Advisory Board: Gelesis Consultant: Medtronic Advisory Board, Consultant, Research Grant, Speakers Bureau: Novo Nordisk |
| Peter H. Jones, MD | Advisory Board, Honoraria: Amarin and Amgen Consultant, Honoraria: Esperion |
| Brian Pearlman, MD | Honoraria, Research Grant, Speakers Bureau: Gilead Sciences Research Grant: Genfit and Novartis |
| Donna H. Ryan, MD | Advisory Board, Consultant: Boehringer Ingelheim, Janssen, Real Appeal, and Sanofi Advisory Board, Consultant, Ownership Interest: Epitomee Medical Advisory Board, Consultant, Research: SELECT Steering Committee, Speakers Bureau: Novo Nordisk Consultant: Alyvant Consultant, Speakers Bureau: Bausch Health Consultant, Ownership Interest: ReDesign Health Ownership Interest: Gila Therapeutics, Phenomix, Scientific Intake, and Xeno Biosciences |
| Jay H. Shubrook, DO | Consultant: Bayer Consultant, Consultant Fee: Eli Lilly Advisory Board: NovoNordisk Research Grant: Sanofi |
| Matthew Weir, MD | Advisory Board: Akebia, Astra, Bayer, Boehringer-Ingelheim, Boston Scientific, CareDX, Janssen, Lexicon, MSD, Relypsa, and Vifor Pharma Research Grant: National Institute of Diabetes and Digestive Kidney: R01DK 066013, NHLBI: R01HL127422, R01HL132732, U01DK106102, and U01DK116095 |
Unlabeled Use Declaration:
During their presentation, faculty may discuss unlabeled or investigational use which is not approved for a commercial product. Faculty members are required to disclose this information to the audience when referring to an unlabeled or investigational use.
Statement of Disclosure and Independence:
It is the policy of Continuing Education Company (CEC) to ensure all of its accredited educational activities are designed, implemented, and evaluated in accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Criteria and Policies. In accordance with ACCME requirements, CEC has Relevant Financial Relationship Disclosure Policies that are designed to ensure that accredited educational activities are fair, balanced, independent, evidence based, and based on scientific rigor.
All individuals who are in position to influence and/or control content of a CEC accredited Continuing Medical Education (CME) activity must disclose any relevant financial interest or other relationships they have with an ineligible company, which is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. (Relevant financial interest or other relationship includes such things as grants or research support, employee, consultant, major stockholder, member of speakers’ bureau, etc.) The intent of this disclosure is to provide activity participants with information to determine whether the speaker’s interests or relationships may influence the presentation with regard to exposition or conclusions. All relevant financial relationships have been identified, mitigated, and are listed above.
The opinions, ideas, recommendations, and perspectives expressed in the syllabus and accompanying presentations at this activity are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations or perspectives of their affiliated institutions, Continuing Education Company, advisory boards or consultants.
Computer Requirements
Flash Player 10 or later, and one of the following browsers:
- Windows: Internet Explorer 6 and later, Microsoft Edge (latest version), Firefox 1.x and later, Google Chrome (latest version), Opera 9.5 and later
- Mac: Safari 3 and later, Firefox 1.x and later, Google Chrome (latest version)
- Linux: Firefox 1.x and later
HTML5 via one of the following browsers:
- Windows: Google Chrome (latest version)
- Mac: Safari 6.0.5 or later, Google Chrome (latest version)
- Mobile: Safari in Apple iOS 6 or later
30 Day Money Back Guarantee
CEC stands behind our product. If you are not satisfied with your online course for any reason, send a written cancellation request and reason to registration@cmemeeting.org within 30 days of the purchase date for a full refund. (Cancellations on CME365™ Collection Series will incur a 5% processing fee.) Please note you may watch any of the content but once you claim credit for any online course, no refund can be granted.